Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1485

1.

Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.

Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.

Pediatr Nephrol. 2018 Jul 7. doi: 10.1007/s00467-018-3994-3. [Epub ahead of print]

PMID:
29982878
2.

High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models.

Valverde-Franco G, Tardif G, Mineau F, Paré F, Lussier B, Fahmi H, Pelletier JP, Martel-Pelletier J.

Rheumatology (Oxford). 2018 Jun 29. doi: 10.1093/rheumatology/key181. [Epub ahead of print]

PMID:
29982662
3.

Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study.

Combès B, Kerbrat A, Ferré JC, Callot V, Maranzano J, Badji A, Le Page E, Labauge P, Ayrignac X, Carra Dallière C, de Champfleur NM, Pelletier J, Maarouf A, de Seze J, Collongues N, Brassat D, Durand-Dubief F, Barillot C, Bannier E, Edan G; EMISEP Study Group.

Mult Scler. 2018 Jun 1:1352458518781999. doi: 10.1177/1352458518781999. [Epub ahead of print]

PMID:
29909771
4.

Clinical diagnosis of partial or complete anterior cruciate ligament tears using patients' history elements and physical examination tests.

Décary S, Fallaha M, Belzile S, Martel-Pelletier J, Pelletier JP, Feldman D, Sylvestre MP, Vendittoli PA, Desmeules F.

PLoS One. 2018 Jun 12;13(6):e0198797. doi: 10.1371/journal.pone.0198797. eCollection 2018.

5.

Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis.

Levy J, Zuckerman J, Garfinkle R, Acuna SA, Touchette J, Vanounou T, Pelletier JS.

HPB (Oxford). 2018 Jun 7. pii: S1365-182X(18)30802-5. doi: 10.1016/j.hpb.2018.04.001. [Epub ahead of print] Review.

PMID:
29887263
6.

Public Health Support for Weight-Related Practices in Child Care Settings in Minnesota.

Pelletier JE, Hassan A, Zukoski AP, Loth K.

Health Promot Pract. 2018 Jun 1:1524839918781523. doi: 10.1177/1524839918781523. [Epub ahead of print]

PMID:
29882436
7.

Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer.

Pelletier J, Cyr SJ, Julien AS, Fradet Y, Lacombe L, Toren P.

Urol Oncol. 2018 Jun 4. pii: S1078-1439(18)30156-X. doi: 10.1016/j.urolonc.2018.05.004. [Epub ahead of print]

PMID:
29880461
8.

eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways.

Cramer Z, Sadek J, Vazquez GG, Di Marco S, Pause A, Pelletier J, Gallouzi IE.

Sci Rep. 2018 May 30;8(1):8414. doi: 10.1038/s41598-018-26625-9.

9.

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.

Tourbah A, Gout O, Vighetto A, Deburghgraeve V, Pelletier J, Papeix C, Lebrun-Frenay C, Labauge P, Brassat D, Toosy A, Laplaud DA, Outteryck O, Moreau T, Debouverie M, Clavelou P, Heinzlef O, De Sèze J, Defer G, Sedel F, Arndt C.

CNS Drugs. 2018 May 28. doi: 10.1007/s40263-018-0528-2. [Epub ahead of print]

PMID:
29808469
10.

Initial derivation of diagnostic clusters combining history elements and physical examination tests for symptomatic knee osteoarthritis.

Décary S, Feldman D, Frémont P, Pelletier JP, Martel-Pelletier J, Fallaha M, Pelletier B, Belzile S, Sylvestre MP, Vendittoli PA, Desmeules F.

Musculoskeletal Care. 2018 May 21. doi: 10.1002/msc.1245. [Epub ahead of print]

PMID:
29781110
11.

How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update.

Maarouf A, Boutière C, Rico A, Audoin B, Pelletier J.

Rev Neurol (Paris). 2018 Jun;174(6):429-440. doi: 10.1016/j.neurol.2018.01.369. Epub 2018 May 17. Review.

PMID:
29779849
12.

Peak vertical force in a stabilized canine cranial cruciate deficient stifle model: A one-year follow-up.

Lussier B, Gagnon A, Moreau M, Pelletier JP, Troncy É.

Can J Vet Res. 2018 Apr;82(2):159-161.

PMID:
29755197
13.

Efficacy of rituximab in refractory RRMS.

Durozard P, Maarouf A, Boutiere C, Ruet A, Brochet B, Vukusic S, Carra-Dalliere C, Labauge P, Mathey G, Debouverie M, Papeix C, Maillart E, Lubetzki C, Bensa C, Gout O, Giannesini C, Stankoff B, Ciron J, Brassat D, Pelletier J, Rico Lamy A, Audoin B; SFSEP and OFSEP groups.

Mult Scler. 2018 May 1:1352458518772748. doi: 10.1177/1352458518772748. [Epub ahead of print]

PMID:
29722639
14.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
15.

Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-Pα,α-Dithiophosphate Analogues.

Zelikman V, Pelletier J, Simhaev L, Sela A, Gendron FP, Arguin G, Senderowitz H, Sévigny J, Fischer B.

J Med Chem. 2018 May 10;61(9):3939-3951. doi: 10.1021/acs.jmedchem.7b01906. Epub 2018 May 2.

PMID:
29681152
16.

[Including recovery in the care pathway after cancer].

Tourette-Turgis C, Gligorov J, Fleury C, Pelletier JF.

Soins. 2018 Apr;63(824):66-68. doi: 10.1016/j.soin.2018.02.016. French.

PMID:
29680144
17.

Examining the Feasibility of Healthy Minimum Stocking Standards for Small Food Stores.

Karpyn A, DeWeese RS, Pelletier JE, Laska MN, Ohri-Vachaspati P, Deahl-Greenlaw A, Ughwanogho O, Jilcott Pitts SB.

J Acad Nutr Diet. 2018 Apr 9. pii: S2212-2672(17)31959-7. doi: 10.1016/j.jand.2017.12.006. [Epub ahead of print]

18.

2'-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO.

Picard-Jean F, Brand C, Tremblay-Létourneau M, Allaire A, Beaudoin MC, Boudreault S, Duval C, Rainville-Sirois J, Robert F, Pelletier J, Geiss BJ, Bisaillon M.

PLoS One. 2018 Mar 30;13(3):e0193804. doi: 10.1371/journal.pone.0193804. eCollection 2018.

19.

Variations in the Peritrophic Matrix Composition of Heparan Sulphate from the Tsetse Fly, Glossina morsitans morsitans.

Rogerson E, Pelletier J, Acosta-Serrano A, Rose C, Taylor S, Guimond S, Lima M, Skidmore M, Yates E.

Pathogens. 2018 Mar 19;7(1). pii: E32. doi: 10.3390/pathogens7010032.

20.

P2Y6 Receptors Regulate CXCL10 Expression and Secretion in Mouse Intestinal Epithelial Cells.

Salem M, Tremblay A, Pelletier J, Robaye B, Sévigny J.

Front Pharmacol. 2018 Feb 28;9:149. doi: 10.3389/fphar.2018.00149. eCollection 2018.

21.

Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.

Katigbak A, Robert F, Paquet M, Pelletier J.

G3 (Bethesda). 2018 May 4;8(5):1627-1635. doi: 10.1534/g3.117.300327.

22.

Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis.

Chowdhury MH, Ryan LK, Cherabuddi K, Freeman KB, Weaver DG, Pelletier JC, Scott RW, Diamond G.

J Fungi (Basel). 2018 Feb 27;4(1). pii: E30. doi: 10.3390/jof4010030.

23.

Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative.

Pelletier JP, Raynauld JP, Abram F, Dorais M, Delorme P, Martel-Pelletier J.

Arthritis Res Ther. 2018 Mar 1;20(1):40. doi: 10.1186/s13075-018-1538-7.

24.

Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial.

du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K, Pelletier JF, Boukhalfi T, Renaud P, Dumais A.

Schizophr Res. 2018 Feb 24. pii: S0920-9964(18)30108-7. doi: 10.1016/j.schres.2018.02.031. [Epub ahead of print]

PMID:
29486956
25.

Evaluation of the Sensitivity of Inhomogeneous Magnetization Transfer (ihMT) MRI for Multiple Sclerosis.

Van Obberghen E, Mchinda S, le Troter A, Prevost VH, Viout P, Guye M, Varma G, Alsop DC, Ranjeva JP, Pelletier J, Girard O, Duhamel G.

AJNR Am J Neuroradiol. 2018 Apr;39(4):634-641. doi: 10.3174/ajnr.A5563. Epub 2018 Feb 22.

PMID:
29472299
26.

Diacerein-containing products: same risk of diarrhoea?

Pelletier JP, Martel-Pelletier J.

Aging Clin Exp Res. 2018 Apr;30(4):411-412. doi: 10.1007/s40520-018-0911-3. Epub 2018 Feb 21. No abstract available.

PMID:
29468617
27.

Beyond molecular tumor heterogeneity: protein synthesis takes control.

Ramon Y Cajal S, Castellvi J, Hümmer S, Peg V, Pelletier J, Sonenberg N.

Oncogene. 2018 May;37(19):2490-2501. doi: 10.1038/s41388-018-0152-0. Epub 2018 Feb 21. Review.

28.

Rocaglates as dual-targeting agents for experimental cerebral malaria.

Langlais D, Cencic R, Moradin N, Kennedy JM, Ayi K, Brown LE, Crandall I, Tarry MJ, Schmeing M, Kain KC, Porco JA Jr, Pelletier J, Gros P.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2366-E2375. doi: 10.1073/pnas.1713000115. Epub 2018 Feb 20.

PMID:
29463745
29.

How Do MRI-Detected Subchondral Bone Marrow Lesions (BMLs) on Two Different MRI Sequences Correlate with Clinically Important Outcomes?

Mattap SM, Aitken D, Wills K, Laslett L, Ding C, Pelletier JP, Martel-Pelletier J, Graves SE, Lorimer M, Cicuttini F, Jones G.

Calcif Tissue Int. 2018 Aug;103(2):131-143. doi: 10.1007/s00223-018-0402-8. Epub 2018 Feb 13.

PMID:
29441423
30.

Therapeutic Opportunities in Eukaryotic Translation.

Chu J, Pelletier J.

Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6). pii: a032995. doi: 10.1101/cshperspect.a032995. Review.

PMID:
29440069
31.

On the Potential of Bulk Metallic Glasses for Dental Implantology: Case Study on Ti40Zr10Cu36Pd14.

Liens A, Etiemble A, Rivory P, Balvay S, Pelletier JM, Cardinal S, Fabrègue D, Kato H, Steyer P, Munhoz T, Adrien J, Courtois N, Hartmann DJ, Chevalier J.

Materials (Basel). 2018 Feb 6;11(2). pii: E249. doi: 10.3390/ma11020249.

32.

Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.

Potvin S, Pelletier J, Grot S, Hébert C, Barr AM, Lecomte T.

Addict Behav. 2018 May;80:154-160. doi: 10.1016/j.addbeh.2018.01.021. Epub 2018 Jan 31. Review.

PMID:
29407687
33.

Soluble antigens in plasma allow mismatched transfusion without hemolysis.

Sikora J, Gregory J, George A, Clayton S, Zou B, Robinson M, Mukhtar F, Pelletier JP.

Transfusion. 2018 Apr;58(4):1006-1011. doi: 10.1111/trf.14510. Epub 2018 Feb 1.

PMID:
29392728
34.

Corrigendum: Ribosome biogenesis in cancer: new players and therapeutic avenues.

Pelletier J, Thomas G, Volarević S.

Nat Rev Cancer. 2018 Jan 25;18(2):134. doi: 10.1038/nrc.2018.3.

PMID:
29368746
35.

Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab.

Meunier B, Rico A, Seguier J, Boutiere C, Ebbo M, Harle JR, Schleinitz N, Pelletier J.

Mult Scler. 2018 May;24(6):811-813. doi: 10.1177/1352458517729766. Epub 2018 Jan 23.

PMID:
29359614
36.

In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis.

Farrán A, Valverde-Franco G, Tío L, Lussier B, Fahmi H, Pelletier JP, Bishop PN, Monfort J, Martel-Pelletier J.

Sci Rep. 2018 Jan 11;8(1):457. doi: 10.1038/s41598-017-18047-w.

38.

Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec 7;23(12):1499. doi: 10.1038/nm1217-1499b.

PMID:
29216045
39.

Ribosome biogenesis in cancer: new players and therapeutic avenues.

Pelletier J, Thomas G, Volarević S.

Nat Rev Cancer. 2018 Jan;18(1):51-63. doi: 10.1038/nrc.2017.104. Epub 2017 Dec 1. Review. Erratum in: Nat Rev Cancer. 2018 Jan 25;18(2):134.

PMID:
29192214
40.

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery.

Robert F, Huang S, Pelletier J.

Curr Gene Ther. 2017;17(4):275-285. doi: 10.2174/1566523217666171121164615.

PMID:
29173168
41.

Eukaryotic initiation factor 4F-sidestepping resistance mechanisms arising from expression heterogeneity.

Chu J, Cajal SRY, Sonenberg N, Pelletier J.

Curr Opin Genet Dev. 2018 Feb;48:89-96. doi: 10.1016/j.gde.2017.11.002. Epub 2017 Nov 21. Review.

PMID:
29169064
42.

Tracking Silent Hypersensitivity Reactions to Asparaginase during Leukemia Therapy Using Single-Chip Indirect Plasmonic and Fluorescence Immunosensing.

Charbonneau DM, Breault-Turcot J, Sinnett D, Krajinovic M, Leclerc JM, Masson JF, Pelletier JN.

ACS Sens. 2017 Dec 22;2(12):1761-1766. doi: 10.1021/acssensors.7b00584. Epub 2017 Dec 4.

PMID:
29168384
43.

New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.

Wybrecht D, Reuter F, Pariollaud F, Zaaraoui W, Le Troter A, Rico A, Confort-Gouny S, Soulier E, Guye M, Maarouf A, Ranjeva JP, Pelletier J, Audoin B.

PLoS One. 2017 Nov 17;12(11):e0184650. doi: 10.1371/journal.pone.0184650. eCollection 2017.

44.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
45.

Diagnostic validity and triage concordance of a physiotherapist compared to physicians' diagnoses for common knee disorders.

Décary S, Fallaha M, Pelletier B, Frémont P, Martel-Pelletier J, Pelletier JP, Feldman DE, Sylvestre MP, Vendittoli PA, Desmeules F.

BMC Musculoskelet Disord. 2017 Nov 14;18(1):445. doi: 10.1186/s12891-017-1799-3.

46.

Validity of Combining History Elements and Physical Examination Tests to Diagnose Patellofemoral Pain.

Décary S, Frémont P, Pelletier B, Fallaha M, Belzile S, Martel-Pelletier J, Pelletier JP, Feldman D, Sylvestre MP, Vendittoli PA, Desmeules F.

Arch Phys Med Rehabil. 2018 Apr;99(4):607-614.e1. doi: 10.1016/j.apmr.2017.10.014. Epub 2017 Nov 9.

PMID:
29128344
47.

Diagnostic Validity of Combining History Elements and Physical Examination Tests for Traumatic and Degenerative Symptomatic Meniscal Tears.

Décary S, Fallaha M, Frémont P, Martel-Pelletier J, Pelletier JP, Feldman DE, Sylvestre MP, Vendittoli PA, Desmeules F.

PM R. 2018 May;10(5):472-482. doi: 10.1016/j.pmrj.2017.10.009. Epub 2017 Oct 27.

PMID:
29111463
48.

Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric study.

Planche V, Moisset X, Morello R, Dumont E, Gibelin M, Charré-Morin J, Saubusse A, Mondou A, Reuter F, Defer G, Pelletier J, Brochet B, Clavelou P.

J Neurol Sci. 2017 Nov 15;382:148-154. doi: 10.1016/j.jns.2017.10.008. Epub 2017 Oct 6.

PMID:
29111011
49.

Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis.

Choi HY, Ruel I, Malina A, Garrod DR, Oda MN, Pelletier J, Schwertani A, Genest J.

Eur Heart J. 2018 Apr 7;39(14):1194-1202. doi: 10.1093/eurheartj/ehx340.

PMID:
29106519
50.

Telephone consultations in urology: Who, when, where, and why?

Blais AS, Pelletier J, Moore K.

Can Urol Assoc J. 2017 Dec;11(12):E453-E456. doi: 10.5489/cuaj.4543. Epub 2017 Nov 1.

Supplemental Content

Loading ...
Support Center